Todos Medical Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Public

  • Employees
  • 7

Employees

  • Stock Symbol
  • TOMDF

Stock Symbol

  • Investments
  • 9

Todos Medical General Information

Description

Todos Medical Ltd is an in vitro diagnostics company. Its operating segments are Breast Cancer Test, Alzheimer's, and COVID-19 testing. The company generates all of its revenue from the United States.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 121 Derech Menachem Begin
  • 30th Floor
  • Tel Aviv 6701203
  • Israel
+972
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Stock Exchange
OTCM
Corporate Office
  • 121 Derech Menachem Begin
  • 30th Floor
  • Tel Aviv 6701203
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Todos Medical Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
816K

Todos Medical Financials Summary

As of 30-Sep-2022, Todos Medical has a trailing 12-month revenue of $10.7M.

In Thousands,
USD
TTM 30-Sep-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 56,632 75,461 18,979 4,182
Revenue 10,749 12,230 5,207 0
EBITDA (16,789) (13,890) (16,305) (10,826)
Net Income (38,768) (43,314) (29,773) (11,815)
Total Assets 14,227 15,115 6,009 91
Total Debt 35,872 31,752 11,443 3,850
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Todos Medical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Todos Medical‘s full profile, request access.

Request a free trial

Todos Medical Patents

Todos Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3144876-A1 A biomarker for alzheimer's disease using blood samples from clinically diagnosed alzheimer's disease subjects Pending 10-Jul-2019
US-20220260595-A1 A biomarker for alzheimer's disease using blood samples from clinically diagnosed alzheimer's disease subjects Inactive 10-Jul-2019
WO-2021005568-A1 A biomarker for alzheimer's disease using blood samples from clinically diagnosed alzheimer's disease subjects Inactive 10-Jul-2019
JP-2022545153-A Alzheimer's disease biomarkers using blood samples from patients with clinically diagnosed alzheimer's disease Pending 10-Jul-2019
EP-3489659-B1 A method of indicating the presence of benign tumors using a peripheral blood mononuclear cells (pbmc) sample Inactive 28-May-2013 G01N33/4833
To view Todos Medical’s complete patent history, request access »

Todos Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Todos Medical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Todos Medical‘s full profile, request access.

Request a free trial

Todos Medical Investments & Acquisitions (9)

Todos Medical’s most recent deal was a Corporate Asset Purchase with NLC Pharma (3CL Protease Biology Assets) for . The deal was made on 16-Mar-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
NLC Pharma (3CL Protease Biology Assets) 16-Mar-2022 Corporate Asset Purchase Buildings and Property
PathNova Laboratories 15-Apr-2021 Seed Round Other Healthcare Technology Systems
NLC Pharma & Todos Medical (J.V) 18-Sep-2020 Joint Venture Drug Discovery
BioImagery 16-Sep-2020 Joint Venture Laboratory Services (Healthcare)
Joint Venture (Care G.B. Plus and Todos Medical) 16-Sep-2020 Joint Venture Laboratory Services (Healthcare)
You’re viewing 5 of 9 investments and acquisitions. Get the full list »

Todos Medical ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Todos Medical’s complete esg history, request access »

Todos Medical Exits (1)

Todos Medical’s most recent exit was on 15-Apr-2021 from PathNova Laboratories. The exit was categorized as with 6 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
PathNova Laboratories 15-Apr-2021 Completed
  • 6 buyers
To view Todos Medical’s complete exits history, request access »

Todos Medical FAQs

  • When was Todos Medical founded?

    Todos Medical was founded in 2010.

  • Where is Todos Medical headquartered?

    Todos Medical is headquartered in Tel Aviv, Israel.

  • What is the size of Todos Medical?

    Todos Medical has 7 total employees.

  • What industry is Todos Medical in?

    Todos Medical’s primary industry is Laboratory Services (Healthcare).

  • Is Todos Medical a private or public company?

    Todos Medical is a Public company.

  • What is Todos Medical’s stock symbol?

    The ticker symbol for Todos Medical is TOMDF.

  • What is Todos Medical’s current revenue?

    The trailing twelve month revenue for Todos Medical is $10.7M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process